Loading viewer...
conference
Format: PDF conference
Nektar Therapeutics presents its biopharmaceutical pipeline and growth strategy at the 2017 JP Morgan Healthcare Conference. The presentation outlines proprietary drug candidates including NKTR-181, NKTR-214, NKTR-358, and NKTR-262, with projected annual revenue of $375-450M by 2021, supported by integrated R&D and manufacturing capabilities.
CDC Mpox Clinical Management Outbreaks Update 2024
conferenceconference
63 Pages
Centers for Disease Control and Prevention
investor_presentation
31 Pages
conference
21 Pages
Keppel REIT
SALGA SDG Implementation Governance 2024
conferenceconference
14 Pages
SALGA (South African Local Government Association)
Analogic Corporation 2017 CJS Conference
conferenceconference
33 Pages
Analogic Corporation